proteomic changes in the hypothalamus and retroperitoneal fat from male f344 rats subjected to...
TRANSCRIPT
RESEARCH ARTICLE
Proteomic changes in the hypothalamus and
retroperitoneal fat from male F344 rats subjected
to repeated light–dark shifts
Archana Mishra1, Chung-Hsien Cheng2, Wen-Chien Lee2 and Ling-Ling Tsai1
1 Department of Psychology, National Chung Cheng University, Chia-yi, Taiwan, ROC2 Department of Chemical Engineering, National Chung Cheng University, Chia-yi, Taiwan, ROC
Received: October 17, 2008
Revised: April 29, 2009
Accepted: May 20, 2009
Chronic circadian desynchronization induced by repeated 12 h light–dark cycle shifts conducted
twice weekly resulted in elevated food intake, body weight gain, and retroperitoneal fat mass in
male F344 rats. Using a proteomic approach, we found that repeated light–dark shifts caused
changes in expression levels of five hypothalamic (four upregulated) and 22 retroperitoneal fat
(13 upregulated) 2-DE protein spots. Proteins involved in carbohydrate metabolism and in the citric
acid cycle were upregulated, indicating a positive energy balance status. In addition, the hypotha-
lamic gamma-amino butyric acid (GABA) aminotransferase was upregulated, thus suggesting a
connection between the brain GABAeric system and the modulation of food intake. Furthermore,
the upregulation of fatty acid-binding protein 4 and the downregulation of 78 kDa glucose-regulated
protein in the fat implicated the development of insulin resistance. We observed the upregulation of
two antioxidant enzymes that might serve as protection against insulin dysfunction associated with
oxidative stress. Finally, the downregulation of hypothalamic voltage-dependent anion-selective
channel protein 1 and fat ATP synthase suggested a reduction in synthesis of mitochondrial ATP.
These findings are in partial agreement with those of studies of obesity induced by genotype and a
high-fat diet.
Keywords:
Animal proteomics / Circadian rhythms / Energy intake / Fat / Obese / Shift work
1 Introduction
Many workers regularly or irregularly work a shift other than a
normal daytime shift. Although there has been little change in
the proportion of those working alternate shifts over the last
three decades, i.e. 15–17% from 1973–1978 [1], 16% in 1985 [2],
17% in 1997 [3], and 18% in 2004 [4] in the US, the number of
shift workers increased to ten million from 1985 to 2004, when
the population of full-time workers is considered. The percen-
tage of shift workers in Europe is 11–23% [5] and is probably
quite similar among other industrialized countries. In contrast
to the advantages that work shift systems provide to employers
and to people who need round-the-clock services, the practice
has repeatedly been reported to have adverse effects on workers
and their families. Obesity is one of the most widespread public
health problems today and most of the survey studies suggest
that shift work is associated with metabolic changes. These
include increased weight gain [6], body mass index [7–13], waist-
to-hip ratio [12–14], and prevalence of overweight [15] and
obesity [7, 16]. The increased rate of these measures in meta-
bolism is also correlated with the duration of shift work status
[9, 11, 13, 15].
The circadian rhythm system can be entrained
(synchronized) to a regular schedule of the Zeitgeber
Abbreviations: FABP4, fatty acid-binding protein 4; GABA,
gamma-aminobutyric acid; GAPDH, glyceraldehyde-3-phos-
phate dehydrogenase; GRP78, 78 kDa glucose-regulated protein;
HT, hypothalamus; LC, control group; LD, light–dark; LS,
repeated light–dark shift group; SCN, suprachiasmatic nucleus;
VDAC1, voltage-dependent anion-selective channel protein 1
Correspondence: Dr. Ling-Ling Tsai, Department of Psychology,
National Chung Cheng University, 168 University Road,
Minhsiung Township, Chiayi County 62102, Taiwan, ROC
E-mail: [email protected]
Fax: 1886-5-2420857
& 2009 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.proteomics-journal.com
Proteomics 2009, 9, 4017–4028 4017DOI 10.1002/pmic.200800813
(time cue, e.g. light–dark (LD) cycle, working/activity time,
meal time, etc.) and become reentrained after several days
when a sudden shift of the Zeitgeber’s phase occurs [17, 18].
In addition, the speed of reentrainment to a new LD cycle is
different between the central circadian pacemaker located in
the suprachiasmatic nucleus (SCN) of the hypothalamus
(HT) and behavioral and physiological rhythms supposedly
regulated by the SCN [19], between different behavioral/
physiological rhythms [20], and even between SCN subdi-
visions [21]. In response to a new feeding cycle, circadian
expression of clock genes such as Per1 in peripheral circa-
dian oscillators also takes several periods to be synchronized
with different speeds in different organs [22, 23]. If the
mealtime is in conflict with the LD cycle, e.g. when food
availability is restricted in the middle of the light period (the
rest period in nocturnal mice and rats), two uncoupled
pacemakers occur: one entrained to mealtime and the other
to the LD cycle. The clock gene expression rhythm in the
liver and other organs is reset gradually and stabilizes
eventually in response to a new mealtime; whereas, the
circadian phase in the SCN is not affected [22–24]. Conco-
mitantly, wheel running activity shows two split rhythms:
one with an intense activity bout before mealtime and the
other with activity mainly occurring in the dark period [25].
Most shift work schedules involve chronic night shifts
and/or shift rotations. Thus, continual practice of shift work
may give rise to disturbances in circadian rhythm systems,
i.e. desynchronization, as long as permanent reentrainment
is not achieved, due to a fast speed of shift rotation or phase
conflicts between different Zeitgebers, e.g. the LD cycle and
mealtime, particularly when workers work at unusual hours
such as nighttime. Experimental evidence supporting the
causal connection between chronic circadian desynchroni-
zation and the consequence of metabolic changes is
presented by two animal paradigms of circadian desyn-
chronization, induced by genetic mutations in the central
clock genes and by artificial manipulations of the Zeitge-
ber’s phase. A mutation in the clock gene Clock or loss of
another clock gene, Bmal1, in mice results in impaired
entrainment of activity rhythm to the LD cycle [26, 27] and
metabolic changes [28–31]. On the other hand, the shifting
of the LD cycle by several hours once or more weekly,
concomitant with ad lib feeding, fixed mealtime, or shifted
mealtime can induce desynchronization in activity and
temperature rhythms in laboratory animals [32–34].
Furthermore, an activity schedule regularly enforced in the
light period or shifting 12 h twice weekly can also induce
disturbances in circadian rhythms [35, 36]. Chronic
manipulations in lighting, feeding, and/or activity sche-
dules, as described above, result in changes in metabolic
measures such as weight gain, food intake, and activity
levels [32–38].
In our previous study [33], we found that repeated 12 h LD
cycle shifts twice weekly resulted in elevated body weight gain
and food intake, and reduced activity levels in male F344 rats.
In this study, we aimed to identify protein molecules in the
HT and retroperitoneal fat specifically related to chronic
circadian desynchronization in the same rat strain under-
going the same shifting schedule of the LD cycle as that
reported in the previous study [33]. The retroperitoneal fat is
one of major abdominal fat depots and composed mainly by
white adipose tissue. The HT is a major homeostatic regu-
latory center involved in body energy balance in the brain. It
receives and integrates the information of energy status from
different sensor mechanisms in response to external cues of
food availability and/or internal metabolic sensory cues of
energy stores and then activates effector mechanisms to
adjust energy intake and expenditure in order to maintain
body energy homeostasis (reviewed in [39, 40]). In addition,
glucose-sensing neurons are found in the lateral and
ventromedial nuclei of the HT; they also respond to fatty
acids and hormones from the periphery (reviewed in [41]). On
the other hand, the adipose tissue is known as a major energy
store, and an endocrine and secretory organ; it releases the
adiposity signal leptin that runs through the circulation
system and interacts with the neurons within the arcuate
nucleus and other HT nuclei associated with energy regula-
tion [39, 40, 42, 43]. The action of leptin in the HT results in
reduced food intake, increased energy expenditure, and
increased lipolytic action in adipose tissues. The brain action
of ghrelin, synthesized primarily in the stomach, and several
hypothalamic neuropeptides, such as neuropeptide Y,
expressed in the arcuate nucleus can also modulate lipid
metabolism and glucose utilization in the fat (reviewed in
[43]). In light of such an intimate connection between the HT
and adipose tissue regarding the regulation of energy
homeostasis, a proteomic approach was applied to reveal the
protein profiles in the HT and adipose tissue that varied with
metabolic changes induced by repeated LD shifts.
2 Material and methods
2.1 Animals
The experimental (LS) and control (LC) rat pairs were
matched on age and body weight recorded at the baseline.
The procedure of LD shifts has previously been described in
detail [33]. Briefly, specific pathogen-free, male inbred rats
(F344/NNarl) aged 6–8 wk were purchased from the
National Laboratory Animal Center, Taipei, Taiwan, ROC.
When the rats were 11–12 wk old, they received aseptic
surgery of sham or temperature/activity transponders (E-
Mitter, Mini-Mitter, Bend, OR, USA) implantation in the
abdomen under isoflurane anesthesia. After 1 wk, when all
of the rats showed a body weight close to the pre-surgical
level, they were subjected to weekly measurements of body
weight, food intake on a regular diet (3.25 kcal/g), and water
intake throughout the experimental period. This included a
1 wk baseline with light exposure from 02:00–14:00, 13 wk of
12 h shifts twice a week in the LD cycle for the LS rats, and
13 wk of a fixed LD cycle except the lights were extended to
4018 A. Mishra et al. Proteomics 2009, 9, 4017–4028
& 2009 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.proteomics-journal.com
24 h every Monday for the LC rats in order to maintain a
weekly light exposure duration equal to that received by the
LS rats (Fig. 1). Both LC and LS rats then underwent 1–3 wk
of a recovery period with the same lighting schedule as that
at the baseline until the daily activity/temperature rhythms
in the LS rats showed reentrainment to the LD cycle
(see Fig. 1). Subsequently, they were killed at 09:00 under
isoflurane without undergoing fasting (for brain samples) or
with 19 h of fasting (for fat samples). The retroperitoneal fat
depot was dissected out from each side of the body. The
kidney and adrenal gland connected to the retroperitoneal
depot were carefully removed prior to weighing the depot.
All brain and fat samples were stored at �701C. All animal
facilities and care followed the guidelines provided by the
Guild for the Care and Use of Laboratory Animals (National
Academy Press, Washington, DC, 1996), and all procedures
and experimental protocols were approved by the National
Chung Cheng University Animal Care and Use Committee.
2.2 Tissue preparation
The frozen rat brain was placed on its dorsal surface on an
aluminum foil paper kept cold on powdered dry ice and a
frontal section was made by the use of a surgical blade. The
HT block was bounded anteriorly at the optic chaism and
posteriorly at the mammillary body and extended dorsally to
the columns of the fornix (anterior) or the mammilotha-
lamic tracts (posterior) and laterally to the telencephalic–
diencephalic junction. The HT samples obtained from six LS
and LC rat pairs and the retroperitoneal fat samples obtained
from eight LS and LC rat pairs were each crushed in a
mortar in the presence of liquid nitrogen. The tissue powder
was then loaded in a microcentrifuge tube and homogenized
using a pestle in 200mL (for HT) or a 1:2 w/v ratio (for
adipose tissue) of lysis buffer containing urea (7 M), thiourea
(2 M), CHAPS (4% w/v), DTT (50 mM), and Bio-Lyte
ampholyte, pH 3–10, (0.2%). The HT suspension was then
centrifuged at 21 000� g at 121C for 72.0 min and the
supernatant (mean protein concentration, 5.472.0 mg/mL,
was collected. For the fat sample, the tissue suspension was
centrifuged at 21 000� g at 181C for 30 min and the interface
between the low-density lipid layer and the insoluble pellet
was carefully collected and spun down again [44]. Total
protein content was quantified based on the method of
Bradford: Protein Assay Dye Reagent Concentrate (BioRad)
was added to the tissue protein solution, it was measured at
595 nm with a spectrophotometer, and the results were
compared with a linear BSA (Sigma-Aldrich) standard curve.
Protein extracts were stored at �801C. When not specified,
the chemical reagents used in each buffer solution were
purchased from Merck or Sigma-Aldrich.
2.3 2-DE
For each 2-DE experiment, a pair of protein samples of the
same tissues randomly selected from one LS and one LC rat
were performed in parallel. Thus, there were six and eight
pairs of 2-DE gels run for the HT and fat, respectively. A
350 mL aliquot of rehydration buffer containing protein
extracts (100 mg), urea (7 M), thiourea (2 M), CHAPS
(2% w/v), DTT (50 mM), and Bio-Lyte ampholyte, pH 3–10,
(0.2%) was applied to each of 18 cm nonlinear pH 3–10 IPG
strip (GE Healthcare) settled in the slot of a strip holder
(BioRad) and rehydrated at 50 V for 16 h at 201C. For IEF,
the BioRad Protean IEF cell was used with the current limit
set at 50mA/IPG strip and with the following conditions at
201C: 500 V for 500 Vh, 1000 V for 1000 Vh, and 8000 V for
57 000 Vh. After IEF, the strips were equilibrated for 15 min
in an equilibration buffer containing urea (6 M), glycerol
(30%), SDS (0.2%), Tris-HCl (50 mM), pH 8.8, and DTT
A
B
Mon Tue Wed Thu Fri Sat Sun
Mon Tue Wed Thu Fri Sat Sun
Fixed Light-Dark Cycle
Shifted Light-Dark Cycle
02:00 08:00 14:00 20:00 02:00 08:00 14:00 20:00 02:00
Rec
ove
ryB
asel
ine
Sh
ifte
d L
igh
t-D
ark
Cyc
le
02:00 08:00 14:00 20:00 02:00 08:00 14:00 20:00 02:00
Figure 1. Weekly lighting schedules over the 13 wk treatment
period (A) and an example of double-plotted body temperature
in one experimental (LS) rat throughout the experimental period
(B). Open and filled horizontal bars represent the light and dark
periods, respectively. Each temperature data point indicates a
mean body temperature difference in 30 s from daily mean body
temperature and is plotted only when it is larger than 0. Vertical
lines on the left side of the temperature graph represent the
period with lights on at 14:00.
Proteomics 2009, 9, 4017–4028 4019
& 2009 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.proteomics-journal.com
(2%), and a further 15 min in the same buffer except DTT
was substituted by iodoacetamide (2.5%). For the second
dimension, equilibrated IPG strips were placed on the top of
SDS-polyacrylamide (12%) gels, and sealed with agarose
(0.5%) containing a trace amount of bromophenol blue.
Electrophoresis was performed at 201C and at 10 mA/gel for
1 h followed by 40 mA/gel until the bromophenol blue
reached the bottom of the gel. Protein spots on the 2-DE gel
were visualized using MS compatible silver stain [45].
2.4 Image analysis
The developed 2-DE gels were scanned using an image
scanner (Amersham Biosciences) at 300 dpi resolution with
a blue filter. Quantitative analysis of protein spot intensity
from 2-DE gel images was performed using Imagemaster
2D Platinum software (version 5.0, Amersham Biosciences).
The relative spot volume was defined as the value of the
intensity integration over the feature area of one spot divi-
ded by the total intensity integration over all of the spots in
the whole gel image.
2.5 Protein digestion
Preparative 2-DE gels loaded with 600–800mg protein
extracts pooled from the same tissues of different animals
were performed following the same conditions described
above except that the protein spots on the 2-DE gel were
stained with Coomassie blue [46]. Selected protein spots
showing statistically significant (po0.05, independent t-test)
rat group differences in relative spot intensity were manu-
ally excised from the preparative 2-DE gel and subjected to
in-gel digestion following the procedure as described in [47]
and with minor modifications. The excised gel plug was
washed twice with 50 mM ammonium acetate and 30%
ACN for 20 min for destaining. The protein in the gel plug
was reduced with 10 mM DTT for 45 min and alkylated with
55 mM iodoacetamide for 45 min in the dark. The gel plug
was then washed twice again with 50 mM ammonium
acetate and 30% ACN as described above, air dried after the
addition of ACN, and digested with 12.5 ng/mL sequencing
grade-modified trypsin (Promega) in 50 mM ammonium
acetate for 18 h at 371C. At the end of digestion, the gel
sample was centrifuged and the supernatant was filtered
through a 0.2 mM nylon filter syringe (Titans, Sun Sri),
dried using a SpeedVac concentrator, and stored at �801C
until MS/MS analysis.
2.6 Protein identification by LC-MS/MS
The tryptic digests were mixed with 10 mL 0.1% formic acid
and filtered through a 0.22 mm nylon syringe filter, and 2mL
of the solution was loaded onto a Bio-Basic capillary C18
column (150 mm� 75 mm, 5mm, 100 A, Thermo Electron,
Bremen, Germany). The mobile phases A and B contained
ACN (5 and 80%, respectively) in 0.1% formic acid. The
peptides were eluted over a linear solvent gradient of 5–60%
over 50 min at a flow rate of 300 nL/min. MS/MS analysis of
the eluted peptides were performed using an LTQ linear ion
trap MS (Thermo Electron) fitted with a nanospray ioniza-
tion source coupled online to an X’TremeSimple nanoflow
LC system (Microtech, Orange, CA, USA). MS/MS spectra
were obtained at a heated capillary temperature of 2001C
with a capillary voltage of 1.2–1.4 kV. MS/MS spectral data
were searched against the National Centre for Biotechnology
Information protein database with Rattus norvegicus speci-
fied and analyzed using the TurboSEQUEST algorithm in
the BioWorks 3.2 software package (Thermo Electron). The
search parameters were as follows: allowing two missed
cleavages; peptide mass tolerance 2 Da; fragment ion toler-
ance 1 Da; permitted modifications including carbamido-
methylated cysteine (157 Da) and oxidized cysteine
(148 Da) and methionine (116 Da); cross-correlation score
(Xcorr) Z1.5 for singly charged ions, Z2.0 for doubly
charged ions, and Z2.5 for triply charged ions; and peptide
probability o0.05. The matched proteins that passed the
above criteria and ranked within the top five peptide prob-
ability scores were further subjected to manual inspection.
The peptide probability indicates the probability that the
peptide is a random match to the spectral data. The best
peptide probability value was transformed into a probability
score (�10 log(peptide probability)). The protein candidate
that had a theoretical Mr within the range of the experi-
mental Mr720% and the highest total number of peptide
matches (more than one match) was finally selected.
2.7 Western blot analysis
The retroperitoneal fat powder was homogenized in 0.25 M
sucrose and then centrifuged at 14 000� g at 181C for
10 min and the interface between the low-density lipid layer
and the insoluble pellet was collected. Total protein content
was quantified using the Protein Assay Rapid Kit (Wako).
Protein samples (15 mg) were separated by electrophoresis
on a 15% polyacrylamide/0.1% SDS gel at 196 V for 3 h and
then electrotransferred to a PolyScreens PVDF membrane
(PerkinElmer) at 41C and 60 V for 15 h. The membrane was
blocked in 5% milk in TBS-Tween 20 (0.05% v/v), incubated
at room temperature for 1 h with a goat polyclonal antibody
(Santa Cruz Biotechnology, Santa Cruz, CA, USA) to fatty
acid-binding protein 4 (FABP4; 1:20,000), and then washed
and incubated at room temperature for 1 h with HRP-
conjugated donkey anti-goat IgG (1:10 000; Santa Cruz
Biotechnology). Bands were detected using the Western
Lightning Plus-ECL detection kit (PerkinElmer) and visua-
lized on Kodak X-Omat Blue XB-1 imaging film. Auto-
radiograms were scanned on a GS-800 calibrated
densitometer (BioRad). Signals were quantified using
4020 A. Mishra et al. Proteomics 2009, 9, 4017–4028
& 2009 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.proteomics-journal.com
Imagemaster 2D Platinum software. We also performed the
western blot analysis on the protein samples prepared for
the 2-DE experiment and followed the same blotting
procedure as described above. The two independent western
blot analyses were named Run1 and Run2, respectively.
2.8 Statistical analysis
Rat group differences were evaluated using independent
t-tests. The degree of association between the relative
protein spot volume and body weight and fat mass was
analyzed by calculating Pearson’s r. All statistical analyses
were performed using SYSTATs 7.0 for Windowss. The
statistical significance level was set at 0.05.
3 Results
Consistent with previous findings [33], the LS rats showed
continual phase shifts, either advanced or delayed, in daily
activity and body temperature (see Fig. 1) rhythms in
response to repeated shifts in the LD cycle. The LS and LC
rats in either tissue sample group maintained comparable
values in the mean food intake and body weight at the
baseline. However, the LS rats ate and gained more weight
than the LC rats during the 13 wk treatment period,
consisting of two 12 h LD shifts per week (Table 1). The
mean retroperitoneal fat mass in absolute weight or relative
weight to body weight was significantly greater in the LS rats
than in the LC rats (Table 1).
There were 519 (SD 5 100) and 679 (129) mean total
protein spots shown in the hypothalamic 2-DE gels of the LS
and LC rats, respectively. When one missing sample was
permitted, there were 203 spots overlapped among all the
gels; among these, five spots showed significant rat group
differences in the relative spot volume (Table 2 and Fig. 2).
The final body weight was not significantly correlated with
the relative spot volume of any of the five protein spots, but
the retroperitoneal fat mass was significantly correlated with
the relative volume of spots 114 (r 5 0.581, po0.05) and 937
(r 5 0.644, po0.05). All five spots were unambiguously
identified (Table S1 of Supporting Information and Table 2),
and they are metabolism-related enzymes or porins. We did
not perform western blot analyses on the HT sample to
validate the proteomic results because of the shortage of the
tissue protein.
There were 632 (71) and 651 (93) mean total protein spots
shown in the retroperitoneal fat 2-DE gels of the LS and LC
rats, respectively. When a maximum of two missing
samples was permitted, there were 337 spots overlapped
among all the gels; among these, 22 spots showed signifi-
cant rat group differences in the relative spot volume
(Table 3 and Fig 3). The final body weight was significantly
correlated with the relative volume of spots 4684 (r 5 0.694,
po0.01), 5335 (r 5 0.688, po0.01), 6159 (r 5 0.543,
po0.05), and 6200 (r 5�0.566, po0.05), and the retro-
peritoneal fat mass was correlated with spots 5335
Table 1. Effects of repeated LD shifts on metabolic variables
HT group Retroperitoneal fat group
LC (n 5 6) LS (n 5 6) LC (n 5 8) LS (n 5 8)
Food intake (g)a)
Baseline 16.9 (1.0) 17.3 (1.3) 19.1 (1.6) 18.8 (0.7)M1 17.0 (1.3) 19.1 (1.1)� 18.5 (1.1) 18.9 (0.5)M2 17.3 (1.8) 18.7 (1.8) 16.8 (1.4) 16.9 (0.4)M3 17.6 (1.7) 18.9 (1.7) 16.2 (1.2) 17.7 (0.9)�
Recovery 18.1 (2.1) 20.1 (1.7) 16.7 (1.9) 19.4 (1.6)��
Body weight (g)b)
Baseline 277 (15) 290 (12) 307 (19) 310 (17)M1 314 (13) 341 (15)�� 345 (15) 359 (15)M2 342 (17) 369 (16)� 356 (19) 370 (13)M3 369 (15) 396 (17)� 384 (19) 410 (16)��
Recovery 375 (21) 398 (17) 383 (20) 410 (17)�
Sacrifice 356 (26) 373 (21) 369 (20) 394 (16)�
Retroperitoneal fat
Absolute weight (g) 5.7 (0.8) 7.6 (1.2)�� 7.3 (1.5) 8.8 (0.8)�
Relative weight (%) 1.59 (0.13)_ 2.04 (0.25)��� 1.97 (0.31) 2.23 (0.20)
a) Daily food intake data were averaged over the days in the baseline, successive months (M1–M3) during LD shifts and recovery,respectively. The rats in the HT sample group underwent a longer recovery period (2–3 wk) than those of the fat sample group becausethose in the HT sample group received glucose and insulin tests during recovery (data not reported). Data are means (SD). Significantdifferences between experimental (LS) and control (LC) rats in the same tissue sample group (�po0.05, ��po0.01, and ���po0.005,independent t-test).
b) Body weight was measured on the last day of baseline, of each successive month during LD shifts and of the first week in recovery andon the day of sacrifice.
Proteomics 2009, 9, 4017–4028 4021
& 2009 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.proteomics-journal.com
(r 5 0.698, po0.01), 6159 (r 5 0.743, po0.01), and 6200
(r 5�0.582, po0.05). Among the 22 spots showing signif-
icant group differences, 17 spots were unambiguously
identified (Table S2 of Supporting Information and Table 3).
Most of the identified proteins are metabolism-related
enzymes. Two proteins (FABP4; and 78 kDa glucose-regu-
lated protein, GRP78) appeared at multiple spots, suggest-
ing that they might be posttranscriptionally and/or
posttranslationally modified. The Western blot analysis on
the fat tissue protein with two independent repetitions
showed that the protein level of FABP4 tended to be higher
in the LS group than in the LC group (Fig. 4).
4 Discussion
Consistent with our previous findings [33], this study
showed that repeated LD shifts increased food intake and
body weight gain in male F344 rats. In addition, this study
found that the LS rats had a greater retroperitoneal fat mass
than the LC rats. A previous study in diet-induced obesity
showed that after 10-wk-old male F344 rats were fed a high-
fat diet (4.47 kcal/g) for 3 wk, their food intake, weight gain,
and retroperitoneal fat mass were 10, 41, and 93%, respec-
tively, greater than those of the control rats fed a low-fat diet
(3.3 kcal/g) [48]. Comparable to the effect of a high-fat diet,
while rats were fed a regular diet (3.25 kcal/g), repeated LD
shifts increased food intake and weight gain to 13 and 35%,
respectively, in the first month (calculated using the data of
the HT sample group). Although repeated LD shifts also
increased body fat accumulation (33% in the HT sample
group and 21% in the fat group), the rate of accumulation
appeared to be lesser efficient than that of a high-fat diet.
Concomitant with changes in food intake, weight gain,
and fat mass, repeated LD shifts resulted in changes in
expression levels of five hypothalamic and 22 retroperitoneal
fat 2-DE protein spots. Among these spots, the expression of
four protein spots in the HT sample and 13 protein spots in
the fat sample was upregulated. Furthermore, the expres-
sion level of two protein spots in the HT and three in the fat
were correlated with the retroperitoneal fat mass; the
expression level of four protein spots in the fat was corre-
lated with body weight. All the five HT protein spots and 17
of the 22 adipose protein spots that were differentially
expressed in response to repeated LD shifts were identified
by MS (see Tables 2 and 3). These proteomic results are
confined in several aspects: (i) Direct comparisons across
2-DE gels may be limited due to inter-gel variation. (ii) The
proteome of whole HT may confound the dynamic changes
in specific HT nuclei involved in different physiological and
behavioral mechanisms. (iii) There is lack of additional
confirmative data, e.g. from immunoassays, for all the
protein spots identified by MS. An exception is FABP4. The
Western blot analysis on FABP4 showed a tendency of rat
group differences consistent with the finding of the
proteomic study.Tab
le2.
Lis
to
fth
ep
rote
insp
ots
dif
fere
nti
all
yexp
ress
ed
inth
era
tH
Taft
er
13
wk
rep
eate
dLD
shif
ts
Sp
ot
no
.Fo
ldch
an
ge
a)
pV
alu
eb
)g
in
o.
Pro
tein
nam
eP
ep
tid
es
matc
hed
%C
overa
ge
c)
Sco
red
)
937
2.3
90.0
33
gi|6978487
Fru
cto
se-b
isp
ho
sph
ate
ald
ola
seA
(EC
4.1
.2.1
3)
727.7
5147
114
1.7
10.0
05
gi|40538860
Aco
nit
ase
2,
mit
och
on
dri
al
(EC
4.2
.1.3
)26
38.0
8126
685
1.3
90.0
08
gi|13591900
GA
BA
am
ino
tran
sfera
se(E
C2.6
.1.1
9)
717.2
075
616
(nLC
55)e
)1.8
20.0
25
gi|62648932
Ald
eh
yd
ed
eh
yd
rog
en
ase
fam
ily
1m
em
ber
B1
(EC
1.2
.1.3
)3
3.8
553
1131
0.1
90.0
04
gi|13786200
VD
AC
11
523.3
277
a)
Rela
tive
spo
tvo
lum
eo
fth
eexp
eri
men
tal
(LS
)g
rou
p/r
ela
tive
spo
tvo
lum
eo
fth
eco
ntr
ol
(LC
)g
rou
p.
b)
Th
ep
valu
ere
pre
sen
tsth
esi
gn
ifica
nce
level
of
the
ind
ep
en
den
tt-
test
.c)
Th
ep
rop
ort
ion
of
the
am
ino
aci
dse
qu
en
ceu
sed
toid
en
tify
the
pro
tein
sis
ind
icate
d.
d)�
10
log
(p)
wh
ere
pis
base
do
nth
ep
rob
ab
ilit
yth
at
the
pep
tid
eis
ara
nd
om
matc
hto
the
spect
ral
data
.T
he
best
pep
tid
ep
rob
ab
ilit
ysc
ore
valu
eis
sho
wn
.e)
Th
esa
mp
lesi
zew
as
6in
bo
thth
eLC
(nLC)
an
dLS
gro
up
s,exce
pt
for
the
pro
tein
spo
tn
o.
616,
du
eto
the
ab
sen
ceo
fa
dis
cern
ab
lesp
ot
ino
ne
gel
sam
ple
.
4022 A. Mishra et al. Proteomics 2009, 9, 4017–4028
& 2009 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.proteomics-journal.com
To our knowledge, this is the first study applying a
proteome analysis approach to identify and quantify hypo-
thalamic proteins related to positive energy balance, i.e.elevated body weight/fat mass setpoint. Most of the five HT
proteins that were differentially expressed in response to
repeated LD shifts are known to be involved in food intake
and/or energy regulation (see Table 2). First, the expression
of the glycolytic enzyme fructose-bisphosphate aldolase A
and the citric acid cycle enzyme aconitase 2 were upregu-
lated in the LS rat group, suggesting a state of elevated
energy supply related to chronic circadian desyncronization.
Upregulation of aldolase and aconitase might also reflect a
central mechanism in the regulation of fat mass since the
expression of the two enzymes was correlated with the
retroperitoneal fat mass. Second, the increased expression of
gamma-amino butyric acid (GABA) aminotransferase
corresponds to the role of the brain GABA mechanism in
the control of food intake in rats. Elevations of brain GABA
induced by intracisternal injection of the GABA amino-
transferase inhibitor produced dose-dependent anorexia in
both normal and obese rats [49–51]. Thus, upregulation of
GABA aminotransferase in the HT suggests attenuated
brain GABA levels, and thus, an enhanced appetite; this
corresponds to increased food intake in the LS rat group.
Aldehyde dehydrogenase family 1 member B1 belongs to a
group of enzymes that play a major role in the oxidation of a
wide range of endogenous aldehydes formed during the
metabolism of carbohydrates, lipids, amino acids, and
exogenous aldehydes such as alcohol [52]. However, the role
of upregulated aldehyde dehydrogenase family 1 member
B1 in the HT is not clear. Last, the only downregulated
protein in the HT, voltage-dependent anion-selective chan-
nel protein 1 (VDAC1), lies in the outer mitochondrial
membrane and plays a crucial role in the regulation of
mitochondrial function [53, 54] and in mitochondrial
apoptosis [55]. Cells with low levels of VDAC1 show a
reduced ATP-synthesis capacity and growth rate. It seems
odd that upregulated aldolase and aconitase, representing
an elevated energy supply, coexists with downregulated
VDAC1, representing a reduced energy supply. How such a
deviation in intracellular energy regulation is involved in
metabolic changes related to circadian desynchronization
requires clarification.
In the retroperitoneal fat, most of the identified proteins
showing differential expression in response to repeated LD
shifts are metabolism-related enzymes (see Table 3).
Consistent with the findings of elevations in all enzymes of
glycolysis, of the pentose phosphate pathway, and of the
citric acid cycle in the adipose tissue derived from geneti-
cally obese Zucker rats (fa/fa) [56], we found that the
expression of the glycolytic enzymes triosephosphate
isomerase, glyceraldehyde-3-phosphate dehydrogenase
(GAPDH), and glycerol-3-phosphate dehydrogenase, the
pentose phosphate pathway enzyme transketolase, and the
citric acid cycle enzyme isocitrate dehydrogenase was higher
in the LS rat group than in the LC rat group. Among these
five upregulated enzymes, GAPDH was the only one
showing expression levels correlated with both body weight
and the retroperitoneal fat mass. Increased GAPDH activity,
specifically in the adipose tissue, has been shown to be
concomitant with a slight but significant increase in
subcutaneous inguinal fat-pad weight detected as early as 7
days of age in obese Zucker pups as compared with lean
heterozygous pups [57]. Thus, a fatty genotype and circadian
desynchronization appear to have a common mechanism in
increasing fat mass involved in an enhanced GAPDH
activity, through which glycolytic flux and supply of
substrates for lipogenesis in adipose tissue is elevated. In
contrast, previous proteomic studies in high-fat-diet-induced
obesity fail to identify any glycolytic enzymes upregulated in
pI
1701309572
55
43
34
26
17
11
kDa
4.0 4.5 5.0 5.5 6.0 6.5 7.0 8.0 9.0 10.0
1701309572
55
43
34
26
17
11
kDa
pI4.0 4.5 5.0 5.5 6.0 6.5 7.0 8.0 9.0 10.0
Figure 2. Hypothalamic 2-DE gels from one control (LC, upper)
and one experimental (LS, lower) rat. Circles indicate protein
spots that showed a higher mean of the relative volume for the
LS group than the LC group.
Proteomics 2009, 9, 4017–4028 4023
& 2009 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.proteomics-journal.com
Tab
le3.
Lis
to
fth
ep
rote
insp
ots
dif
fere
nti
all
yexp
ress
ed
inth
era
tre
tro
peri
ton
eal
fat
aft
er
13
wk
rep
eate
dLD
shif
ts
Sp
ot
no
.Fo
ldch
an
ge
a)
pV
alu
eb
)g
in
o.
Pro
tein
nam
eP
ep
tid
es
matc
hed
%C
overa
ge
c)
Sco
red
)
3800
(nLC
5n
LS
57)
1.4
70.0
27
gi|62647962
Tri
ose
ph
osp
hate
iso
mera
se(E
C5.3
.1.1
)3
14.1
654
6159
1.3
20.0
19
gi|62647964
GA
PD
H(E
C1.2
.1.1
2)
36.3
190
3284
1.8
90.0
04
gi|57527919
Gly
cero
l-3-p
ho
sph
ate
deh
yd
rog
en
ase
[NA
D1
],cy
top
lasm
ic(E
C1.1
.1.8
)10
30.6
667
1548
(nLS
57)
1.5
40.0
45
gi|12018252
Tra
nsk
eto
lase
(EC
2.2
.1.1
)12
23.6
6125
2619
1.6
60.0
38
gi|16758446
Iso
citr
ate
deh
yd
rog
en
ase
[NA
D1
]su
bu
nit
alp
ha,
mit
och
on
dri
al
(EC
1.1
.1.4
1)
822.9
580
5335
1.9
80.0
22
gi|62643089
FA
BP
42
21.2
182
5647
1.4
20.0
41
gi|62643089
FA
BP
48
52.2
787
5702
2.5
80.0
07
gi|62643089
FA
BP
45
37.1
083
3398
2.2
30.0
28
gi|62652539
3-M
erc
ap
top
yru
vate
sulf
urt
ran
sfera
se(E
C2.8
.1.2
)8
27.6
170
3918
1.9
50.0
38
gi|34855391
Bil
iverd
inre
du
ctase
B(E
C1.3
.1.2
4)
426.2
1160
3458
1.7
50.0
10
3872
2.4
10.0
11
4684
2.3
40.0
44
2252
0.5
60.0
44
gi|40538742
AT
Psy
nth
ase
sub
un
italp
ha,
mit
och
on
dri
al
48.1
081
2091
0.5
50.0
10
gi|6980956
Glu
tam
ate
deh
yd
rog
en
ase
1,
mit
och
on
dri
al
(EC
1.4
.1.3
)4
8.0
674
1189
(nLC
57)e
)0.5
90.0
06
gi|42476287
Tra
nsg
luta
min
ase
2,
Cp
oly
pep
tid
e(E
C2.3
.2.1
3)
14
25.2
2104
1167
0.7
30.0
47
gi|16758748
Dyn
ein
,cy
top
lasm
ic,
inte
rmed
iate
po
lyp
ep
tid
e2
611.4
4141
1882
0.6
40.0
39
gi|51036655
Alp
ha-1
-an
tip
rote
inase
12
28.2
295
6200
(nLS
56)
0.4
40.0
28
gi|25742763
GR
P78
24
38.6
9121
6201
(nLC
56)
0.5
20.0
11
gi|25742763
GR
P78
20
39.1
4126
1776
0.6
60.0
25
1787
(nLC
57)
0.6
70.0
10
a)
Rela
tive
spo
tvo
lum
eo
fth
eexp
eri
men
tal
(LS
)g
rou
p/r
ela
tive
spo
tvo
lum
eo
fth
eco
ntr
ol
(LC
)g
rou
p.
b)
Th
ep
valu
ere
pre
sen
tsth
esi
gn
ifica
nce
level
of
the
ind
ep
en
den
tt-
test
.c)
Th
ep
rop
ort
ion
of
the
am
ino
aci
dse
qu
en
ceu
sed
toid
en
tify
the
pro
tein
sis
ind
icate
d.
d)�
10
log
(p)
wh
ere
pis
base
do
nth
ep
rob
ab
ilit
yth
at
the
pep
tid
eis
ara
nd
om
matc
hto
the
spect
ral
data
.T
he
best
pep
tid
ep
rob
ab
ilit
ysc
ore
valu
eis
sho
wn
.e)
Th
esa
mp
lesi
zew
as
8in
bo
thth
eLC
(nLC)
an
dLS
(nLS)
gro
up
s,exce
pt
for
som
ep
rote
ins,
du
eto
the
ab
sen
ceo
fd
isce
rnab
lesp
ots
inso
me
gel
sam
ple
s.
4024 A. Mishra et al. Proteomics 2009, 9, 4017–4028
& 2009 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.proteomics-journal.com
the fat in obese rats [44] or mice but have identified one
downregulated in obese mice [58]. Downregulation in
glycolytic enzymes is assumed to reflect that at elevated
plasma fatty acids concentrations resulting from a high-fat
diet, fatty acids compete with glucose as an oxidative fuel
source.
However, diet-induced obese rats show upregulation of a
cytosolic fatty acid chaperone, FABP4, also known as
adipocyte-fatty-acid-binding protein, in the epidydimal fat; it
is reverted by treatment with the antiobesity agent tungstate
[44], which decreases body weight gain and adiposity with-
out modifying food intake in obese rats [59]. The LS rats in
this study also showed upregulation of FABP4 in the
retroperitoneal fat. One of the multiple protein spots iden-
tified as FABP4 (5335) showed that expression levels were
correlated positively with both body weight and the retro-
peritoneal fat mass. Recently, plasma FABP4 released from
adipocytes was found to be higher in overweight/obese
individuals than in lean persons and correlated positively
with obesity and metabolic syndrome [60]. However, mice
deficient in FABP4 are not protected from genetic or high-
fat-diet-induced obesity and, when fed a regular diet, have
higher elevated plasma fatty acids than wild-type mice.
Although increased plasma fatty acids are positively corre-
lated with the development of obesity and insulin resistance
in general, mice deficient in FABP4 are more insulin
sensitive (reviewed in [61]). If the upregulation of FABP4 is
a critical link between obesity and insulin resistance, the
development of insulin resistance is predicted for the LS rats
in the long run. Furthermore, we have found multiple
protein spots identified as FABP4 and all of them were
consistently upregulated in the LS rat group. Whether
these multiple protein spots represent specific protein
0
2
4
6
8
10
12
Run1 Run2
FA
BP
4 co
nten
t (a
rbit
rary
uni
ts)
LC LS
15kDa
21_CL10_SL LC_02 LS_11
Figure 4. Representative Western blot analyses from two control
(LC_02, LC_12) and two experimental (LS_01, LS_11) rats and
mean densitometric results (the error bar depicts SEM) of FABP4
in the retroperitoneal fat tissue. A two-factor (two-rat groups two
runs) analysis of variance showed a tendency of rat group
difference to be significant (F1,13=4.03, p=0.066; n=7 in the LC
group due to one tissue sample unavailable for Western blot
analyses).
4.0 4.5 5.0 5.5 6.0 6.5 7.0 8.0 9.0 10.0pI
170
130
95
72
55
43
34
26
17
kDa
4.0 4.5 5.0 5.5 6.0 6.5 7.0 8.0 9.0 10.0pI
170
130
95
72
55
43
34
26
17
kDa
Figure 3. Retroperitoneal fat 2-DE gels from one control (LC,
upper) and one experimental (LS, lower) rat. Circles indicate
protein spots that showed a higher mean of the relative volume
for the LS group than the LC group.
Proteomics 2009, 9, 4017–4028 4025
& 2009 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.proteomics-journal.com
modifications requires further study. For example, it has
been shown that high-fat-diet-induced obesity results in an
increase in the carbonylation of a number of adipose-regu-
latory proteins including FABP4 [62]. Protein carbonylation
is mediated by reactive aldehydes in response to oxidative
stress. It is postulated that increased protein carbonylation
and oxidative stress are components linking obesity to
insulin resistance. In contrast, the upregulation of two
antioxidant enzymes, 3-mercaptopyruvate sulfurtransferase
and biliverdin reductase B, in the LS rat group might serve
as a compensatory mechanism in response to increased
reactive oxygen species resulting from increased metabolic
processes, and thereby, might protect the body from
(excessive) oxidative stress. To what extent upregulation in
antioxidant enzymes can protect the body from insulin
resistance in LS rats could not be predicted by this study.
In contrast to the proteome of high-fat-diet-induced
obesity that shows upregulation in ATP synthase in fat [44],
the LS rats had a lower expression level of ATP synthase.
ATP synthase has been found in both the mitochondrial and
plasma membrane. Mitochondrial ATP synthase is the
central enzymatic complex of mitochondrial oxidative
phosphorylation and the cell-surface ATP synthase complex
contributes to the regulation of signal transduction. The
expression of the cell-surface ATP synthase is markedly
increased during adipogenesis and inhibition of ATP
synthase activity by ATP synthase inhibitors or by antibodies
against ATP synthase inhibits lipid accumulation in adipo-
cytes [63]. Thus, it appears paradoxical that the LS rats had a
greater fat mass and a lower expression level of ATP
synthase than the LC rats. However, a reduced expression
level of mitochondrial ATP synthase might represent an
adaptation mechanism to elevated energy supply. Reduction
in mitochondrial ATP synthase may increase the uncou-
pling of ATP generation from respiratory chain oxidation,
which leads to increased proton leakage, resulting in more
energy dissipated as heat.
Glutamate dehydrogenase, a key regulator of amino acid
and ammonia metabolism, was downregulated in the LS
rats. Glutamate dehydrogenase activity in brown adipose
tissues is lower in diet-induced obese rats than in control
lean rats [64], and this, accompanied by reductions in the
activity of other amino acid metabolism-related enzymes in
adipose tissues, represents an adaptive mechanism of
depressed amino acid utilization as fuel in obese rats. The
other four downregulated proteins in the LS rats were tissue
glue protein transglutaminase 2, cellular structure protein
dynein, plasma protein alpha1 antiproteinase, and chaperon
GRP78. The role of the first three above-mentioned proteins
in metabolism and obesity is not clear. The expression of
GRP78 does not change in the fat of diet-induced obese rats
but is upregulated after tungstate treatment [44]. In addi-
tion, mice with a fat-specific insulin receptor knock-out
show an elevated expression level of GRP78 in adipose
tissues accompanied by reduced fat mass and protection
against age-related and hypothalamic lesion-induced obesity
and obesity-related glucose intolerance [65, 66]. In this
study, it was found that the expression level of GRP78 was
negatively correlated with both body weight and the retro-
peritoneal fat mass. Thus, downregulation of GRP78 in the
LS rats might be related to the development of obesity and
insulin resistance.
In summary, rats undergoing chronic circadian desyn-
chronization induced by repeated LD cycle shifting consis-
tently showed increased food intake, weight gain, and fat
mass, accompanied by expression changes in several
proteins in the HT and fat. Those identified proteins
involved in carbohydrate metabolism and citric acid cycle
were upregulated in the HT and fat, which might reflect a
positive energy balance status. On the other hand, upregu-
lation of the GABA metabolic enzyme in the HT suggested
that a suppressed GABAeric system might be responsible
for enhanced food intake induced by repeated LD shifts.
Furthermore, upregulation of FABP4 and downregulation
of GRP78 predicted the development of insulin resistance.
However, upregulation of antioxidant enzymes might serve
as protection against oxidative stress-related insulin
dysfunction. Thus, how insulin function responds to repe-
ated LD shifts awaits future studies.
This work was supported by the National Science Council(NSC), Taiwan R. O. C., Grant NSC95-2413-H-194-029-MY2.AM was supported by the NSC Postdoctoral Research FellowGrants NSC95-2811-H-194-002 and NSC96-2811-H-194-001.We thank Yu-Che Tsai and Kuang-Jen Huang for their assis-tance in tissue dissection, Wan-Chen Wang for her participationin the proteome experiment, Wen-Peng Lin and Yu-Chin Chenfor their work on the LC-MS/MS analysis performed in theDepartment of Chemistry and Biochemistry at the NationalChung Cheng University, and Ya-Wen Liu, Fan-Ci Hsiao, Yu-Shan Huang, and Chun-Yu Chen for their work on the westernblot analysis performed at Dr. Hsien-Bin Huang’s laboratory inthe Department of Life Sciences at the National Chung ChengUniversity.
The authors have declared no conflict of interest.
5 References
[1] Hedges, J. N., Sekscenski, E. S., Workers on late shifts in a
changing economy. Mon. Labor Rev. 1979, 102, 14–22.
[2] Mellor, E. F., Shift work and flexitime: how prevalent are
they? Mon. Labor Rev. 1986, 109, 14–21.
[3] Beers, T. M., Flexible schedules and shift work: replacing
the ‘9-to-5’ workday? Mon. Labor Rev. 2000, 123, 33–40.
[4] McMenamin, T. M., A time to work: recent trends in shift work
and flexible schedules. Mon. Labor Rev. 2007, 130, 3–15.
[5] Bauer, F., GroX, H., Sieglen, G., Schwarz, M., Betriebszeit-
und Arbeitszeitmanagement. Ergebnisse einer repr .asenta-
tiven Betriebsbefragung in Europa, LIT Verlag, M .unster
2005.
4026 A. Mishra et al. Proteomics 2009, 9, 4017–4028
& 2009 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.proteomics-journal.com
[6] Geliebter, A., Gluck, M. E., Tanowitz, M., Aronoff, N. J.,
Zammit, G. K., Work-shift period and weight change.
Nutrition 2000, 16, 27–29.
[7] Di Lorenzo, L., De Pergola, G., Zocchetti, C., L’Abbate, N.
et al., Effect of shift work on body mass index: results of a
study performed in 319 glucose-tolerant men working in a
Southern Italian industry. Int. J. Obes. Relat. Metab. Disord.
2003, 27, 1353–1358.
[8] Ishizaki, M., Morikawa, Y., Nakagawa, H., Honda, R. et al.,
The influence of work characteristics on body mass index
and waist to hip ratio in Japanese employees. Ind. Health
2004, 42, 41–49.
[9] Kawachi, I., Colditz, G. A., Stampfer, M. J., Willett, W. C.
et al., Prospective study of shift work and risk of coronary
heart disease in women. Circulation 1995, 92, 3178–3182.
[10] Morikawa, Y., Nakagawa, H., Miura, K., Soyama, Y. et al.,
Effect of shift work on body mass index and metabolic
parameters. Scand. J. Work Environ. Health 2007, 33, 45–50.
[11] Parkes, K. R., Shift work and age as interactive predictors of
body mass index among offshore workers. Scand. J. Work
Environ. Health 2002, 28, 64–71.
[12] Rosmond, R., Lapidus, L., Bjorntorp, P., The influence of
occupational and social factors on obesity and body fat
distribution in middle-aged men. Int. J. Obes. Relat. Metab.
Disord. 1996, 20, 599–607.
[13] Van Amelsvoort, L. G., Schouten, E. G., Kok, F. J., Duration
of shiftwork related to body mass index and waist to hip
ratio. Int. J. Obes. Relat. Metab. Disord. 1999, 23, 973–978.
[14] Ha, M., Park, J., Shiftwork and metabolic risk factors of
cardiovascular disease. J. Occup. Health 2005, 47, 89–95.
[15] Niedhammer, I., Lert, F., Marne, M. J., Prevalence of over-
weight and weight gain in relation to night work in a nurses’
cohort. Int. J. Obes. Relat. Metab. Disord. 1996, 20, 625–633.
[16] Karlsson, B., Knutsson, A., Lindahl, B., Is there an associa-
tion between shift work and having a metabolic syndrome?
Results from a population based study of 27,485 people.
Occup. Environ. Med. 2001, 58, 747–752.
[17] Aschoff, J., Hoffmann, K., Pohl, H., Wever, R., Re-entrain-
ment of circadian rhythms after phase-shifts of the Zeitge-
ber. Chronobiologia 1975, 2, 23–78.
[18] Liu, T., Borjigin, J., Reentrainment of the circadian pace-
maker through three distinct stages. J. Biol. Rhythms 2005,
20, 441–450.
[19] Takamure, M., Murakami, N., Takahashi, K., Kuroda, H.,
Etoh, T., Rapid reentrainment of the circadian clock itself,
but not the measurable activity rhythms to a new light-dark
cycle in the rat. Physiol. Behav. 1991, 50, 443–449.
[20] Satoh, Y., Kawai, H., Kudo, N ., Kawashima, Y., Mitsumoto, A.,
Temperature rhythm reentrains faster than locomotor rhythm
after a light phase shift. Physiol. Behav. 2006, 88, 404–410.
[21] Nagano, M., Adachi, A., Nakahama, K., Nakamura, T. M.
et al., An abrupt shift in the day/night cycle causes desyn-
chrony in the mammalian circadian center, J. Neurosci.
2003, 23, 6141–6151.
[22] Damiola, F., Le Minh, N., Preitner, N., Kornmann, B. et al.,
Restricted feeding uncouples circadian oscillators in
peripheral tissues from the central pacemaker in the
suprachiasmatic nucleus. Genes Dev. 2000, 14, 2950–2961.
[23] Stokkan, K. A., Yamazaki, S., Tei, H., Sakaki, Y., Menaker, M.,
Entrainment of the circadian clock in the liver by feeding.
Science 2001, 291, 490–493.
[24] Hara, R., Wan, K., Wakamatsu, H., Aida, R. et al., Restricted
feeding entrains liver clock without participation of the
suprachiasmatic nucleus. Genes Cells 2001, 6, 269–278.
[25] Mistlberger, R. E., Circadian food-anticipatory activity:
formal models and physiological mechanisms. Neurosci.
Biobehav. Rev. 1994, 18, 171–195.
[26] Vitaterna, M. H., King,D. P., Chang, A. M., Kornhauser, J. M.
et al., Mutagenesis and mapping of a mouse gene, Clock,
essential for circadian behavior. Science 1994, 264, 719–725.
[27] Bunger, M. K., Wilsbacher, L. D., Moran, S. M., Clendenin,
C., Mop3 is an essential component of the master circadian
pacemaker in mammals. Cell 2000, 103, 1009–1017.
[28] Rudic, R. D., McNamara, P., Curtis, A. M., Boston, R. C. et al.,
BMAL1 and CLOCK, two essential components of the
circadian clock, are involved in glucose homeostasis. PLoS
Biol. 2004, 2, e377.
[29] Turek, F. W., Joshu, C., Kohsaka, A., Lin, E. G. et al., Obesity
and metabolic syndrome in circadian Clock mutant mice.
Science 2005, 308, 1043–1045.
[30] Oishi, K., Atsumi, G., Sugiyama, S., Kodomari, I. et al., Disrup-
ted fat absorption attenuates obesity induced by a high-fat diet
in Clock mutant mice. FEBS Lett. 2006, 580, 127–130.
[31] Shimba, S., Ishii, N., Ohta, Y., Ohno, T. et al., Brain and
muscle Arnt-like protein-1 (BMAL1), a component of the
molecular clock, regulates adipogenesis. Proc. Natl. Acad.
Sci. USA. 2005, 102, 12071–12076.
[32] Nelson, W., Halberg, F., Schedule-shifts, circadian rhythms
and lifespan of freely-feeding and meal-fed mice. Physiol.
Behav. 1986, 38, 781–788.
[33] Tsai, L.-L., Tsai, Y.-C., Hwang, K., Huang, Y.-W., Tzeng, J.-E.,
Repeated light-dark shifts speed up body weight gain in
male F344 rats. Am. J. Physiol. Endocrinol. Metab. 2005,
289, E212–E217.
[34] Bartol-Munier, I., Gourmelen, S., Pevet, P., Challet, E.,
Combined effects of high-fat feeding and circadian desyn-
chronization. Int. J. Obes. 2006, 30, 60–67.
[35] Tsai, L. L., Tsai, Y. C., The effect of scheduled forced wheel
activity on body weight in male F344 rats undergoing
chronic circadian desynchronization. Int. J. Obes. 2007, 31,
1368–1377.
[36] Salgado-Delgado, R., Angeles-Castellanos, M., Buijs, M. R.,
Escobar, C., Internal desynchronization in a model of night-
work by forced activity in rats. Neuroscience 2008, 154,
922–931.
[37] Kort, W. J., Weijma, J. M., Effect of chronic light-dark shift
stress on the immune response of the rat. Physiol. Behav.
1982, 29, 1083–1087.
[38] Kort, W. J., Zondervan, P. E., Hulsman, L. O., Weijma, I. M.,
Westbroek, D. L., Light-dark-shift stress, with special refer-
ence to spontaneous tumor incidence in female BN rats.
J. Natl. Cancer Inst. 1986, 76, 439–446.
Proteomics 2009, 9, 4017–4028 4027
& 2009 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.proteomics-journal.com
[39] Novak, C. M., Levine, J. A., Central neural and endocrine
mechanisms of non-exercise activity thermogenesis and
their potential impact on obesity. J. Neuroendocrinol. 2007,
19, 923–940.
[40] Gao, Q., Horvath, T. L., Neuronal control of energy home-
ostasis. FEBS Lett. 2008, 582, 132–141.
[41] Levin, B. E., Metabolic sensing neurons and the control of
energy homeostasis. Physiol. Behav. 2006, 89, 486–489.
[42] Angelopoulos, N., Goula, A., Tolis, G., Current knowledge in
the neurophysiologic modulation of obesity. Metabolism
2005, 54, 1202–1217.
[43] Nogueiras, R., Wilson, H., Rohner-Jeanrenaud, F., Tschop,
M. H., Central nervous system regulation of adipocyte
metabolism. Regul. Pept. 2008, 149, 26–31.
[44] Barcelo-Batllori, S., Corominola, H., Claret, M., Canals, I.
et al., Target identification of the novel antiobesity agent
tungstate in adipose tissue from obese rats. Proteomics
2005, 5, 4927–4935.
[45] Yan, J. X., Wait, R., Berkelman, T., Harry, R. A. et al., A
modified silver staining protocol for visualization of
proteins compatible with matrix-assisted laser desorption/
ionization and electrospray ionization-mass spectrometry.
Electrophoresis 2000, 21, 3666–3672.
[46] Candiano, G., Bruschi, M., Musante, L., Santucci, L. et al.,
Blue silver: a very sensitive colloidal Coomassie G-250
staining for proteome analysis. Electrophoresis 2004, 25,
1327–1333.
[47] Kumarathasan, P., Mohottalage, S., Goegan, P., Vincent, R.,
An optimized protein in-gel digest method for reliable
proteome characterization by MALDI-TOF-MS analysis.
Anal. Biochem. 2005, 346, 85–89.
[48] Levin, B. E., Dunn-Meynell, A. A., McMinn, J. E., Alperovich, M.
et al., A new obesity-prone, glucose-intolerant rat strain (F.DIO).
Am. J. Physiol. Regul. Integr. Comp. Physiol. 2003, 285,
R1184–R1191.
[49] Coscina, D. V., GABA and feeding: reversal of overeating by
central GABA-transaminase inhibition. Prog. Neuropsy-
chopharmacol. Biol. Psychiatry 1983, 7, 463–467.
[50] Coscina, D. V., Nobrega, J. N., Anorectic potency of inhi-
biting GABA transaminase in brain: studies of hypotha-
lamic, dietary and genetic obesities. Int. J. Obes. 1984, 8,
191–200.
[51] Nobrega, J. N., Snow, J., Dixon, L. M., Coscina, D. V.,
Graded increases in brain GABA: differential effects on
feeding and other behaviours in rats. Behav. Brain Res.
1988, 31, 135–147.
[52] Vasiliou, V., Pappa, A., Polymorphisms of human aldehyde
dehydrogenases. Consequences for drug metabolism and
disease. Pharmacology 2000, 61, 192–198.
[53] Hodge, T., Colombini, M., Regulation of metabolite flux
through voltage-gating of VDAC channels. J. Membr. Biol.
1997, 157, 271–279.
[54] Rostovtseva, T., Colombini, M., VDAC channels mediate
and gate the flow of ATP: implications for the regulation of
mitochondrial function. Biophys. J. 1997, 72, 1954–1962.
[55] Abu-Hamad, S., Sivan, S., Shoshan-Barmatz, V., The
expression level of the voltage-dependent anion channel
controls life and death of the cell. Proc. Natl. Acad. Sci. USA
2006, 103, 5787–5792.
[56] Spydevold, S. O., Greenbaum, A. L., Baquer, N. Z., McLean, P.,
Adaptive responses of enzymes of carbohydrate and lipid
metabolism to dietary alteration in genetically obese Zucker
rats (fa/fa). Eur. J. Biochem. 1978, 89, 329–339.
[57] Dugail, I., Quignard-Boulange, A., Bazin, R., Le Liepvre, X.,
Lavau, M., Adipose-tissue-specific increase in glycer-
aldehyde-3-phosphate dehydrogenase activity and mRNA
amounts in suckling pre-obese Zucker rats. Effect of wean-
ing. Biochem. J. 1988, 254, 483–487.
[58] Schmid, G. M., Converset, V., Walter, N., Sennitt, M. V.
et al., Effect of high-fat diet on the expression of proteins in
muscle, adipose tissues, and liver of C57BL/6 mice.
Proteomics 2004, 4, 2270–2282.
[59] Claret, M., Corominola, H., Canals, I., Saura, J. et al.,
Tungstate decreases weight gain and adiposity in obese
rats through increased thermogenesis and lipid oxidation.
Endocrinology 2005, 146, 4362–4369.
[60] Xu, A., Wang, Y., Xu, J. Y., Stejskal, D. et al., Adipocyte fatty
acid-binding protein is a plasma biomarker closely asso-
ciated with obesity and metabolic syndrome. Clin. Chem.
2006, 52, 405–413.
[61] Furuhashi, M., Hotamisligil, G. S., Fatty acid-binding
proteins: role in metabolic diseases and potential as drug
targets. Nat. Rev. Drug Discov. 2008, 7, 489–503.
[62] Grimsrud, P. A., Picklo,M. J., Sr., Griffin, T. J., Bernlohr, D. A.,
Carbonylation of adipose proteins in obesity and insulin resis-
tance: identification of adipocyte fatty acid-binding protein as a
cellular target of 4-hydroxynonenal. Mol. Cell. Proteomics 2007,
6, 624–637.
[63] Arakaki, N., Kita, T., Shibata, H., Higuti, T., Cell-surface
H1-ATP synthase as a potential molecular target for anti-
obesity drugs. FEBS Lett. 2007, 581, 3405–3409.
[64] Serra, F., Gianotti, M., Pons, A., Palou, A., Brown and white
adipose tissue adaptive enzymatic changes on amino acid
metabolism in persistent dietary-obese rats. Biochem. Mol.
Biol. Int. 1994, 32, 1173–1178.
[65] Bl .uher, M., Michael, M. D., Peroni, O. D., Ueki, K. et al.,
Adipose tissue selective insulin receptor knockout protects
against obesity and obesity-related glucose intolerance.
Dev. Cell 2002, 3, 25–38.
[66] Bl .uher, M., Wilson-Fritch, L., Leszyk, J., Laustsen, P. G.
et al., Role of insulin action and cell size on protein
expression patterns in adipocytes. J. Biol. Chem. 2004, 279,
31902–31909.
4028 A. Mishra et al. Proteomics 2009, 9, 4017–4028
& 2009 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.proteomics-journal.com